4.7 Article

Disordered oropharyngeal microbial communities in H7N9 patients with or without secondary bacterial lung infection

Journal

EMERGING MICROBES & INFECTIONS
Volume 6, Issue -, Pages -

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1038/emi.2017.101

Keywords

H7N9; microbiota-targeted prophylactic therapies; oropharyngeal microbiome; secondary bacterial lung infection

Funding

  1. National Natural Science Foundation of China [81501431, 81600506, 81671557]
  2. National Basic Research Program (973) of China [2013CB531401, 2013CB531406]
  3. Natural Science Foundation of Zhejiang Province [LY15H030012, LY16H270001]
  4. Zhejiang Province Health Department Program [2014KYA075]
  5. Zhejiang Province Science and Technology Department Non-profit Program [2014C33199]

Ask authors/readers for more resources

Secondary bacterial lung infection (SBLI) is a serious complication in patients with H7N9 virus infection, and increases disease severity. The oropharyngeal (OP) microbiome helps prevent colonisation of respiratory pathogens. We aimed to investigate the OP microbiome of H7N9 patients with/without secondary bacterial pneumonia using 16S rRNA gene sequencing. OP swab samples were collected from 51 H7N9 patients (21 with SBLI and 30 without) and 30 matched healthy controls (HCs) and used for comparative composition, diversity and richness analyses of microbial communities. Principal coordinates analysis successfully distinguished between the OP microbiomes of H7N9 patients and healthy subjects, and the OP microbiome diversity of patients with SBLI was significantly increased. There was significant dysbiosis of the OP microbiome in H7N9 patients, with an abundance of Leptotrichia, Oribacterium, Streptococcus, Atopobium, Eubacterium, Solobacterium and Rothia species in patients with SBLI, and Filifactor, Megasphaera and Leptotrichia species in patients without SBLI, when compared with HCs. Importantly, Haemophilus and Bacteroides species were enriched in HCs. These findings revealed dysbiosis of the OP microbiota in H7N9 patients, and identified OP microbial risk indicators of SBLI, suggesting that the OP microbiome could provide novel and non-invasive diagnostic biomarkers for early microbiota-targeted prophylactic therapies for SBLI prevention.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available